Sabbah A
Laboratoire d'Immuno-Allergologie, C.H.U. Angers, France.
Allerg Immunol (Paris). 1986 Jan;18(1):41-3.
A double blind check was conducted in two groups of patients with asthma to test ribosomal fraction (Ribomunyl) in a new tablet form: -the first group of 15 patients received the active medicine; -the second group of 9 patients were given placebos. The therapy consisted in prescribing 3 tablets a day for the first 4 days of the week for 3 weeks, next to stop treatment for one month, then to resume treatment for 4 days every month. Clinical improvement was reported in patients who were given the medicine. The "Rosettes" Test is in favor of a stimulation of T lymphocytes with correction of the cellular mediation deficit in the groups that received treatment.
对两组哮喘患者进行了双盲检查，以测试新片剂形式的核糖体组分（力保美达）：第一组15名患者接受活性药物；第二组9名患者服用安慰剂。治疗方法是在一周的前4天每天开3片药，持续3周，然后停药1个月，之后每月恢复治疗4天。服用药物的患者报告有临床改善。“玫瑰花环”试验表明，接受治疗的组中T淋巴细胞受到刺激，细胞介导缺陷得到纠正。
